Sustainability | May 08, 2025
Granules India bags EcoVadis’ Gold Rating
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
Gelhaus has a proven track record of driving business growth
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
The FDA issued Form 483 with one observation related to building and facility management
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The Q1 2025 also witnessed a successful launch of Allegra D
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Subscribe To Our Newsletter & Stay Updated
